Affymetrix and Applied Biosystems Enter into Licensing Agreement
News Dec 26, 2005
Affymetrix, Inc. and Applied Biosystems Group, an Applera Corporation business, have announced that Applera has taken a non-exclusive, worldwide license to a number of Affymetrix patents related to the manufacture, sale, and use of microarrays for gene expression analysis.
The license will be applied to the continued expansion of the Applied Biosystems Expression Array System for high density microarray analysis and will enable customers to use that system for gene expression, research and development purposes.
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.